切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2025, Vol. 14 ›› Issue (01) : 25 -29. doi: 10.3877/cma.j.issn.2095-3232.2025002

专家论坛

吲哚菁绿在解剖性肝切除术中的应用
吴哲境1, 李敬东1,(), 熊永福1, 刘刚1, 陈雷1   
  1. 1.637000 四川省南充市,川北医学院附属医院肝胆外一科
  • 收稿日期:2024-10-21 出版日期:2025-02-10
  • 通信作者: 李敬东
  • 基金资助:
    川北医学院附属医院科研发展计划项目(2021YS004)

Application of indocyanine green in anatomical hepatectomy

Zhejing Wu1, Jingdong Li1,(), Yongfu Xiong1, Gang Liu1, Lei Chen1   

  1. 1.Department I of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, China
  • Received:2024-10-21 Published:2025-02-10
  • Corresponding author: Jingdong Li
引用本文:

吴哲境, 李敬东, 熊永福, 刘刚, 陈雷. 吲哚菁绿在解剖性肝切除术中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 25-29.

Zhejing Wu, Jingdong Li, Yongfu Xiong, Gang Liu, Lei Chen. Application of indocyanine green in anatomical hepatectomy[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2025, 14(01): 25-29.

肝癌已成为全世界常见恶性肿瘤之一,目前治疗肝癌方式众多,其中解剖性肝切除是国内外公认的肝癌治疗首选及最佳的手术方式,但解剖性肝切除仍存在局限性。ICG 由于其独特的荧光性质,被用于肝脏手术过程中的荧光显像,在辅助解剖性肝切除术中起着重要作用,近年来也有报道应用于肝癌术前介入治疗中。本文就ICG 在解剖性肝切除的发展及其应用现状进行相关综述。

Liver cancer has become one of the common malignant tumors worldwide.At present,multiple approaches have been employed to treat liver cancer.Among them, anatomical hepatectomy is recognized as the recommended and optimal surgical treatment for liver cancer at home and abroad, whereas it still has certain limitations.Due to specific fluorescence properties, indocyanine green (ICG) can be used for fluorescence imaging during liver surgery and plays a pivotal role in assisting anatomical hepatectomy.In recent years, ICG has also been reported to be applied in preoperative interventional therapy of liver cancer.In this article, the development and application of ICG in anatomical hepatectomy were reviewed.

[1]
Singal AG, Lampertico P, Nahon P.Epidemiology and surveillance for hepatocellular carcinoma: new trends[J].J Hepatol, 2020, 72(2):250-261.
[2]
Vibert E, Schwartz M, Olthoff KM.Advances in resection and transplantation for hepatocellular carcinoma[J].J Hepatol, 2020,72(2):262-276.
[3]
Kolligs FT, Hoffmann RT, den Winkel MO, et al.Diagnosis and multimodal therapy for hepatocellular carcinoma[J].Z Gastroenterol,2010, 48(2):274-288.
[4]
Hasegawa K, Kokudo N, Imamura H, et al.Prognostic impact of anatomic resection for hepatocellular carcinoma[J].Ann Surg, 2005,242(2):252-259.
[5]
Ishizawa T, Saiura A, Kokudo N.Clinical application of indocyanine green-fluorescence imaging during hepatectomy[J].Hepatobiliary Surg Nutr, 2016, 5(4):322-328.
[6]
解剖性与非解剖性肝切除术的选择[J].中国实用外科杂志, 2018,38(4):418-419, 422.
[7]
Makuuchi M, Hasegawa H, Yamazaki S.Ultrasonically guided subsegmentectomy[J].Surg Gynecol Obstet, 1985, 161(4):346-350.
[8]
Eguchi S, Kanematsu T, Arii S, et al.Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey[J].Surgery, 2008, 143(4):469-475.
[9]
Li SQ, Huang T, Shen SL, et al.Anatomical versus non-anatomical liver resection for hepatocellular carcinoma exceeding Milan criteria[J].Br J Surg, 2017, 104(1):118-127.
[10]
Ishizawa T, Gumbs AA, Kokudo N, et al.Laparoscopic segmentectomy of the liver: from segment Ⅰ to Ⅷ[J].Ann Surg, 2012, 256(6):959-964.
[11]
Cucchetti A, Qiao GL, Cescon M, et al.Anatomic versus nonanatomic resection in cirrhotic patients with early hepatocellular carcinoma[J].Surgery, 2014, 155(3):512-521.
[12]
Sasaki Y, Yamada T, Tanaka H, et al.Risk of recurrence in a long-term follow-up after surgery in 417 patients with hepatitis B- or hepatitis C-related hepatocellular carcinoma[J].Ann Surg, 2006, 244(5):771-780.
[13]
Katz SC, Shia, Liau KH, et al.Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma[J].Ann Surg, 2009, 249(4):617-623.
[14]
Mindt S, Karampinis I, John M, et al.Stability and degradation of indocyanine green in plasma, aqueous solution and whole blood[J].Photochem Photobiol Sci, 2018, 17(9):1189-1196.
[15]
徐继玲, 田继海.荧光腹腔镜的工作原理及应用[J].世界最新医学信息文摘, 2019, 19(33):238.
[16]
Ogata F, Azuma R, Kikuchi M, et al.Novel lymphography using indocyanine green dye for near-infrared fluorescence labeling[J].Ann Plast Surg, 2007, 58(6):652-655.
[17]
Ishizawa T, Bandai Y, Kokudo N.Fluorescent cholangiography using indocyanine green for laparoscopic cholecystectomy: an initial experience[J].Arch Surg, 2009, 144(4):381-382.
[18]
杨雯雯, 田宏伟, 雷彩宁, 等.吲哚菁绿荧光导航技术在腹腔镜肝胆胰外科手术中的研究进展[J].中国普通外科杂志, 2021, 30(8):979-986.
[19]
Mizumoto M, Oshiro Y, Sakurai H.Significance of indocyanine green test in radiotherapy for hepatocellular carcinoma[J].Transl Cancer Res, 2019, 8(1):14-16.
[20]
刘允怡, 方驰华, 王晓颖,等.吲哚菁绿分子荧光影像技术诊断原发性肝癌与术中导航操作诊疗规范(2021版)[J].中国实用外科杂志,2021,41(9):1002-1013,1032.
[21]
方驰华, 王晓颍, 刘允怡.计算机辅助联合吲哚菁绿分子荧光影像技术在肝脏肿瘤诊断和手术导航中应用指南(2019版)[J].中国实用外科杂志, 2019, 39(7):641-650,654.
[22]
张树庚, 刘连新.吲哚菁绿荧光融合影像引导技术在腹腔镜肝切除中的应用及展望[J].中华肝胆外科杂志, 2019, 25(2):129-131.
[23]
彭宇明, 尹强, 高红强, 等.吲哚菁绿荧光染色引导下解剖性右半肝切除治疗儿童肝脏肿瘤[J].临床小儿外科杂志, 2018, 17(8):597-599, 625.
[24]
Aoki T, Yasuda D, Shimizu Y, et al.Image-guided liver mapping using fluorescence navigation system with indocyanine green for anatomical hepatic resection[J].World J Surg, 2008, 32(8):1763-1767.
[25]
王宏光.吲哚菁绿肝段染色在腹腔镜肝癌切除中应用及意义[J].中国实用外科杂志, 2018, 38(4):376-378.
[26]
Zhang YM, Shi R, Hou JC, et al.Liver tumor boundaries identified intraoperatively using real-time indocyanine green fluorescence imaging[J].J Cancer Res Clin Oncol, 2017, 143(1):51-58.
[27]
Achterberg FB, Sibinga Mulder BG, Meijer RPJ, et al.Realtime surgical margin assessment using ICG-fluorescence during laparoscopic and robot-assisted resections of colorectal liver metastases[J].Ann Transl Med, 2020, 8(21):1448.
[28]
Tashiro Y, Aoki T, Hirai T, et al.Pathological validity of using near-infrared fluorescence imaging for securing surgical margins during liver resection[J].Anticancer Res, 2020, 40(7):3873-3882.
[29]
Lu H, Gu J, Qian XF, et al.Indocyanine green fluorescence navigation in laparoscopic hepatectomy: a retrospective single-center study of 120 cases[J].Surg Today, 2021, 51(5):695-702.
[30]
张玮琪, 卓嘉明, 方驰华.ICG分子荧光影像技术用于肝脏肿瘤手术安全性和有效性 Meta 分析[J].中国实用外科杂志, 2019, 39(7):729-734.
[31]
Yang J, Tao HS, Cai W, et al.Accuracy of actual resected liver volume in anatomical liver resections guided by 3-dimensional parenchymal staining using fusion indocyanine green fluorescence imaging[J].J Surg Oncol, 2018, 118(7):1081-1087.
[32]
Qi C, Zhang H, Chen Y, et al.Effectiveness and safety of indocyanine green fluorescence imaging-guided hepatectomy for liver tumors: a systematic review and first meta-analysis[J].Photodiagnosis Photodyn Ther, 2019, 28:346-353.
[33]
Chen H, Cheng H, Dai Q, et al.A superstable homogeneous lipiodol-ICG formulation for locoregional hepatocellular carcinoma treatment[J].J Control Release, 2020, 323:635-643.
[34]
He P, Xiong Y, Ye J, et al.A clinical trial of super-stable homogeneous lipiodol-nanoICG formulation-guided precise fluorescent laparoscopic hepatocellular carcinoma resection[J].J Nanobiotechnology, 2022,20(1):250.
[35]
He P, Xiong Y, Luo B, et al.An exploratory human study of superstable homogeneous lipiodol-indocyanine green formulation for precise surgical navigation in liver cancer[J].Bioeng Transl Med,2023, 8(2): e10404.
[36]
Urade T, Sawa H, Iwatani Y, et al.Laparoscopic anatomical liver resection using indocyanine green fluorescence imaging[J].Asian J Surg, 2020, 43(1):362-368.
[37]
Ishizawa T, Fukushima N, Shibahara J, et al.Real-time identification of liver cancers by using indocyanine green fluorescent imaging[J].Cancer, 2009, 115(11):2491-2504.
[38]
Gotoh K, Yamada T, Ishikawa O, et al.A novel image-guided surgery of hepatocellular carcinoma by indocyanine green fluorescence imaging navigation[J].J Surg Oncol, 2009, 100(1):75-79.
[39]
胡伟建, 李仓, 吴晓康, 等.三维可视化联合吲哚菁绿荧光影像实时导航在腹腔镜右肝精准解剖性肝切除中的应用[J].中华普通外科杂志, 2024, 39(8):626-628.
[40]
孟令展, 俞鹏, 李虎, 等.ICG荧光导航腹腔镜肝右前叶切除术[J/OL].中华肝脏外科手术学电子杂志, 2023, 12(5):590.
[1] 钟锴, 蒋铁民, 张瑞青, 吐尔干艾力·阿吉, 邵英梅, 郭强. 加速康复外科在肝囊型棘球蚴病肝切除术中的应用分析[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 425-429.
[2] 冷建军, 朴成林, 司振铎. 胰十二指肠切除术联合小范围肝切除、血管切除重建[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 384-384.
[3] 朴成林, 蓝炘, 司振铎, 李强, 冯健, 安峰铎, 冷建军. 胰十二指肠切除联合肝切除术疗效分析:附5例报告(附视频)[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 363-367.
[4] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[5] 冯旺, 马振中, 汤林花. CT扫描三维重建在肝内胆管细胞癌腹腔镜肝切除术中的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 104-107.
[6] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[7] 唐梅, 周丽, 牛岑月, 周小童, 王倩. ICG荧光导航的腹腔镜肝切除术临床意义[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 655-658.
[8] 胡森焱, 徐冬, 方健, 谢冬冬, 王财庆. ICG荧光显影Laennec膜入路腹腔镜解剖性肝切除的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 513-516.
[9] 林巧, 周丽. RFA联合LAH术治疗原发性肝癌并门静脉癌栓的临床效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 521-524.
[10] 杭轶, 杨小勇, 李文美, 薛磊. 可控性低中心静脉压技术在肝切除术中应用的最适中心静脉压[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 813-817.
[11] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[12] 袁雨涵, 杨盛力. 体液和组织蛋白质组学分析在肝癌早期分子诊断中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 883-888.
[13] 吴警, 吐尔洪江·吐逊, 温浩. 肝切除术前肝功能评估新进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 889-893.
[14] 吴雪云, 胡小军, 范应方. 肝切除术中剩余肝再生能力的评估与预测[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 894-897.
[15] 广东省护士协会介入护士分会, 广东省医师协会介入医师分会. 原发性肝癌低血糖患者护理规范管理专家共识[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 709-714.
阅读次数
全文


摘要